НовостиBenzingaPolyrizon Completes Participant Enrollment In Its Trial Of NASARIX To Treat Airborne Allergens Polyrizon Completes Participant Enrollment In Its Trial Of NASARIX To Treat Airborne Allergens Benzinga 2026.10.27 12:20 (GMT+0) Открыть на Benzinga Другие новости